Archive for the ‘Babesia’ Category

Novel Treatment For Relapsing Lyme, Babesia, and Bartonella

https://www.mdpi.com/2076-2607/11/9/2301

Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated Coinfections

by 1,2,*, 2 and Phyllis R. Freeman2
Microorganisms 202311(9), 2301; https://doi.org/10.3390/microorganisms11092301
Received: 8 August 2023 / Revised: 27 August 2023 / Accepted: 8 September 2023 / Published: 12 September 2023
(This article belongs to the Special Issue Bartonella and Bartonellosis: New Advances and Further Challenges)

Abstract

Twenty-five patients with relapsing and remitting Borreliosis, Babesiosis, and bartonellosis despite extended anti-infective therapy were prescribed double-dose dapsone combination therapy (DDDCT), followed by one or several courses of High Dose Dapsone Combination Therapy (HDDCT). A retrospective chart review of these 25 patients undergoing DDDCT therapy and HDDCT demonstrated that 100% improved their tick-borne symptoms, and patients completing 6–7 day pulses of HDDCT had superior levels of improvement versus 4-day pulses if Bartonella was present.
At the completion of treatment, 7/23 (30.5%) who completed 8 weeks of DDDCT followed by a 5–7 day pulse of HDDCT remained in remission for 3–9 months, and 3/23 patients (13%) who recently finished treatment were 1 ½ months in full remission.
In conclusion, DDDCT followed by 6–7 day pulses of HDDCT could represent a novel, effective anti-infective strategy in chronic Lyme disease/Post Treatment Lyme Disease Syndrome (PTLDS) and associated co-infections, including Bartonella, especially in individuals who have failed standard antibiotic protocols.
_____________
For more:

Pregnancy, Breast Feeding & Lyme

https://danielcameronmd.com/pregnancy-breast-feeding-and-lyme/

PREGNANCY, BREAST FEEDING AND LYME

By Dr. Daniel Cameron

Welcome to another selection from my book “An Expert’s Guide on Navigating Lyme disease.” The book highlights the findings of my first 600 Lyme disease Science blogs.  In this episode, I will discuss pregnancy, breast feeding, and Lyme disease.

Pregnancy and breast feeding are particularly concerning topics for Lyme disease patients and their doctors. Here are few findings to help with discussions.

Pregnancy and Lyme.

If a woman is bit by a deer tick or contracts Lyme disease (LD) while pregnant, she must immediately alert her treating physician. Poor outcomes have been described for newborns whose mothers contracted Lyme disease during pregnancy.
 Studies have found that stillbirths occurred when LD was contracted during the first trimester. Markowitz et al., 1986, Schlesinger et al., 1985, and MacDonald et al., 1987) Gestational Lyme borreliosis has been described in 5 of 19 pregnancies (26%) resulting in “syndactyly, cortical blindness, intrauterine fetal death, prematurity, and rash” (Markowitz et al., 1986).

A newborn died at 39 hours of life with a left-sided hypoplastic heart and the presence of spirochetes consistent with Bb [Borrelia burgdorferi] “in the spleen, kidneys, and bone marrow” (Schlesinger et al., 1985). Bb was also cultured from fetal liver tissue in 4 stillborn infants (MacDonald 1986). 
There was insufficient evidence to determine the risk to a child if their mother contracted Lyme disease before pregnancy (Mylonas 2011). A study of 2,000 women with a history of LD did not show an increased risk of fetal death, decreased birth weight, or length of gestation at delivery. There was an increase in the number of congenital defects but the risk may have been by chance alone (Strobino et al., 1993).

Choosing an antibiotic regimen for pregnant women with Lyme disease can be a complex challenge. Amoxicillin, cefuroxime, azithromycin, and IV ceftriaxone have been prescribed for pregnant women (Maraspin et al., 2009).

Author’s note: More studies will be needed to understand pregnancy and breast feeding concerns.

Breast feeding and Lyme.

The CDC addressed the question “Can Lyme disease be transmitted through breast milk?” They announced, “No reports of breast milk spreading Lyme disease to infants exist” (CDC 2022).
There is insufficient data to determine if breastfeeding can transmit Bb to the child. 
Certain antibiotic classes, such as tetracyclines, should not be used in breastfeeding women being treated for Lyme disease to avoid the risk of side effects, such as tooth discoloration. The child’s clinician can help guide treatment options for a breastfeeding mother. Read more.

Diversity of clinical presentations of Lyme and pregnancy.

Doctors followed 11 pregnant women with Lyme disease from 2008 to 2020. “In the present study, we report our case series, which includes 11 pregnant women, 6 of whom developed erythema migrans during pregnancy (between weeks 8 and 34), 3 had monoarticular or neurological symptoms, and 2 had positive serology but did not develop any clinical symptoms” (Trevisan et al., 2020).

All mothers were treated with amoxicillin 1g 3x/ day for 14 days. One child was born prematurely at seven months. Another child was born with angiomatoid patches that regressed spontaneously 18 months later. One of the pregnant women with Lyme disease, confirmed by spinal tap and labs, experienced articular and neurologic involvement and improved with amoxicillin. However, she required treatment with intravenous ceftriaxone because of persistent symptoms. Read more.

Two mothers transmit Lyme to their babies.

Babesia can be contracted from the bite of a deer tick, a blood transfusion, or during pregnancy. This podcast reviews a case in which Babesia was transmitted from mothers to their babies during pregnancy.

Questions raised in the podcast include: 
• How often do mothers contract Babesia from a tick bite during pregnancy?
• Is there an effective and safe treatment for Babesia in pregnant women?
• How does a mother or doctor recognize Babesia in a pregnant mother?
• Should doctors follow pregnant mothers with a tick bite or Lyme disease for Babesia and what evidence should be investigated? 
• Will the mothers develop complications of Babesia in the future if not treated?
• Should the two mothers have been treated for Babesia? Read more.

A baby girl with Lyme disease.

Slovenian researchers investigated whether Borrelia burgdorferi bacteria, the pathogen causing Lyme disease, might impact pregnancy outcomes. 
Pregnancy outcome was unfavorable in 13.8% (42/304) of patients. They found that the outcome of pregnancy in Lyme disease patients was not significantly worse.

There were 22 pre-term births, 10 fetal/perinatal deaths, and/or 15 anomalies. Several mothers had potential explanations for their unfavorable pregnancy outcomes. The poor outcome for Lyme disease patients was not significantly different compared to the general population (Maraspin et al., 2020).

Author’s note: The study did not follow the 262 women who gave birth with a favorable outcome for any long-term problems. Nor did the authors describe the outcome for women who were not treated for early Lyme disease. Read more.

Little information on treatment of tick bites during pregnancy.

Smith et al., (2020) argue that “high-level evidence” supports using a single 200 mg dose of doxycycline for tick bites during pregnancy. The evidence they cited is not high-level. Instead, they focused on a small Meta-Analysis study.
 Regrettably, there is no evidence that a single 200 mg dose of doxycycline prevents other manifestations of Lyme disease, such as heart block, 7th nerve palsy, Lyme arthritis, Lyme encephalopathy, or Neuropsychiatric Lyme disease. Read more.

Congenital transmission of Babesia to a 5-year-old twin.

A baby girl was born to a mother who showed no evidence of Lyme or a related tick-borne illness during her pregnancy (Walker et al., 2022). The 5-week-old female diamniotic dichorionic twin was born at 36 5/7 weeks by C-section and diagnosed with Babesia. Her twin brother was asymptomatic.
The mother described several trips to Cape Cod, Massachusetts, an area endemic to Lyme disease.

“The patient’s mother had one febrile illness during pregnancy, occurring at approximately 23-24 weeks of gestation, associated with a maculopapular rash that resolved spontaneously” (Walter et al., 2022). 
The daughter was treated with a blood transfusion, intravenous atovaquone twice daily, and azithromycin daily. The authors of the article pictured a blood smear with intraerythrocytic inclusions consistent with Babesia microti. Read more.

Delayed onset Babesia in two newborns.

A study from the Mayo clinic described two newborn infants diagnosed with Babesia several weeks after the mothers were treated for Lyme disease (Hoversten and Bartlett, 2018).
 Infant 1:
 A baby boy was diagnosed with Babesia at 4-1/2 weeks. His mother had been diagnosed and treated for early Lyme disease at 32 weeks gestation.  
Infant 2: 
A baby girl was diagnosed with Babesia at 18-days-old. Her mother had been diagnosed and treated for early Lyme disease at 37 weeks gestation.
 Neither mother was treated for Babesia during their pregnancy. Read more.

________________

**Comment**

Lyme/MSIDS has recognized for over 40 years, yet very little has been done relating to pregnancy, breastfeeding, effective treatments, persistence, and transmission.  The fact so much work on supposed ‘climate change’ should prove to anyone with a functioning brain that something isn’t right.  While thousands suffer, the only thing we have to show for it is mountains of data on ticks and the climate, despite independent research proving ticks are marvelously ecoadaptive as well as pointing out erroneous, biased, shoddy research being used to support a faulty model to push a climate narrative.

The fact that infected moms have had babies die, and the fact they have cultured spirochetes in the heart, liver, spleen, kidneys, and bone marrow of infants should raise alarming red flags.

Regarding the CDC’s statement on breastfeeding – just because something hasn’t been reported, doesn’t mean it doesn’t happen.

Any red flags simply get buried under climate data.  

For more:

The Use of Natural Bioactive Nutraceuticals in the Management of Tick-Borne Illnesses

https://www.mdpi.com/2076-2607/11/7/1759

The Use of Natural Bioactive Nutraceuticals in the Management of Tick-Borne Illnesses

By Samuel M. Shor and Sunjya K. Schweig

Microorganisms 202311(7), 1759; https://doi.org/10.3390/microorganisms11071759
Received: 14 May 2023 / Revised: 29 June 2023 / Accepted: 29 June 2023 / Published: 5 July 2023

Abstract

The primary objective of this paper is to provide an evidence-based update of the literature on the use of bioactive phytochemicals, nutraceuticals, and micronutrients (dietary supplements that provide health benefits beyond their nutritional value) in the management of persistent cases of Borrelia burgdorferi infection (Lyme disease) and two other tick-borne pathogens, Babesia and Bartonella species. Recent studies have advanced our understanding of the pathophysiology and mechanisms of persistent infections. These advances have increasingly enabled clinicians and patients to utilize a wider set of options to manage these frequently disabling conditions. This broader toolkit holds the promise of simultaneously improving treatment outcomes and helping to decrease our reliance on the long-term use of pharmaceutical antimicrobials and antibiotics in the treatment of tick-borne pathogens such as Borrelia burgdorferiBabesia, and Bartonella (See link for full article)
___________________
Go here for an excellent article on the above study which breaks it down for the lay person.  The following graph is within the article and will interest you:

For a full list of all 30+ bioactive nutraceuticals, see Appendix A. Summary of Clinical Impact.

For more:

Babesia Causes False-Positive HIV Results

https://danielcameronmd.com/babesiosis-false-positive-hiv-test-results/

BABESIOSIS CAUSES FALSE-POSITIVE HIV TEST RESULTS

babesiosis-hiv-test

It is believed that Babesia may cause false-positive HIV test results, possibly due to Babesia and HIV serologies cross-reacting, according to a new study, “Acute Babesiosis Causing a False-Positive HIV Result: An Unexpected Association,” by He and colleagues.

Investigators describe the case of a patient with acute babesiosis who prior to treatment tested positive for HIV.

The 60-year-old man was admitted to the emergency department with intermittent fever, fatigue, anorexia, and worsening jaundice for three weeks. He was referred by his primary care doctor due to abnormal laboratory values and parasites in the blood.

A blood smear showed Babesia microti with 1-2% infected red blood cells. “Given the patient’s severe presentation but relatively low percentage of infected red blood cells, HIV testing was done,” the authors write.

The fourth-generation HIV 1/2 antigen/antibody test was initially positive but after treatment, HIV testing was negative.

“Our case report adds to the small amount of literature showing that false-positive HIV testing in patients with babesiosis is possible.”

The patient was treated for Babesia with atovaquone and azithromycin and doxycycline to cover other possible tick-borne diseases.

“An exchange transfusion was performed due to the patient’s severe presentation,” according to the authors.

The patient’s symptoms resolved following treatment. And repeat testing for HIV was negative.

“False-positive fourth-generation HIV tests are rare,” the authors point out. However, a few case reports “have described false-positive HIV tests associated with acute babesiosis.”

The authors conclude:

  • “While the reasons for false-positive HIV tests in acute babesiosis remain unclear, physicians who see patients with a positive HIV test in the setting of acute babesiosis should pursue further workup.”
References:
  1. He JZ, Rezwan M, Arif A, Baroud S, Elhaj M, Khan A. Acute Babesiosis Causing a False-Positive HIV Result: An Unexpected Association. Case Rep Infect Dis. 2023 Jul 24;2023:6271710. doi: 10.1155/2023/6271710. PMID: 37528903; PMCID: PMC10390267.

________________

**Comment**

Well now, isn’t that something?  

Please consider the following:

He states:

  • SARS-CoV-2 appears to be a benign bat coronavirus modified to integrate spike proteins that allows the virus to enter human cells by attaching to ACE-2 receptors
  • The virus also appears to have been modified to integrate an envelope protein from HIV called GP141, which tends to impair the immune system. A third modification appears to involve nanotechnology, which allows the virus to remain airborne longer

Paralyzed by Lyme, They Were Helped With Combo Treatments

https://www.lymedisease.org/remission-from-lyme-paralysis/

Paralyzed by Lyme, they were helped with combo treatments

By Lonnie Marcum

July 19, 2023

A new study from France looks at the use of combination antibiotics and anti-parasitic treatments in patients with limb paralysis as a result of tick-borne infections, including Lyme disease.

Approximately 70% of the patients in this study showed complete remission of symptoms after long-term treatment—a statistic that lines up with the MyLymeData treatment study.

The paper entitled, Complete Remission in Paralytic Late Tick-Borne Neurological Disease Comprising Mixed Involvement of Borrelia, Babesia, Anaplasma, and Bartonella: Use of Long-Term Treatments with Antibiotics and Antiparasitics in a Series of 10 Cases was published in Antibiotics.

The inclusion criteria for this study required a score of 4 or more on the Kurtzke EDSS disability scale; positive blood tests for one or more tick-borne pathogen (including Borrelia burgdorferi, Babesia, Anaplasma or Bartonella); and chronic general symptoms including fatigue, pain, and cognitive deficits lasting six or more months.

The Extended Disability Status Scale (EDSSis a tool commonly used to quantify the level of disability in patients with multiple sclerosis. The EDSS grades six bodily functions, including visual, brain, bowel/bladder and sensory functions, as well as the patients’ ability to walk and take care of themselves.

All 10 of the patients that qualified for this study were severely disabled with partial or complete paralysis in at least one limb. Five of the 10 required a wheelchair for mobility, and four required assistive devices like walking sticks to get around.

Complete remission for 7 out of 10

Following extended treatment, seven out of 10 patients (70%) showed complete remission of symptoms. Among the nine patients with positive Borrelia serology (along with co-infections), 77% obtained complete remission.

The treatment administered varied according to the patient’s infection profile. The majority of the patients received repeated oral regimens of azithromycin-doxycycline and azithromycin-doxycycline-rifampin plus a minimum of three 35-day cycles of IV ceftriaxone. The eight patients co-infected with Babesia (a parasite) were also administered anti-parasitic cycles of atovaquone–azithromycin. The mean duration of treatment was 20 months +/- 6 months. (Trouillas 2023)

Historically, patients with late-stage Lyme disease have poor outcomes to single regimens of 10-day IV ceftriaxone. (I’ve previously written about brain inflammation, and small fiber neuropathy found in patients with continuing symptoms after short-term treatment for Lyme disease.)

And we have decades of strong evidence that under-treatment with single antibiotics is consistent with persistent infection in animal studies. (Embers 2012)

Two weeks isn’t enough

As far back as 1990, Dr. Allen Steere co-authored a paper on patients with persistent late-stage neurological Lyme disease.

In this paper Dr. Steere and his co-authors state:

Months to years after the initial infection with B. burgdorferi, patients with Lyme disease may have chronic encephalopathy, polyneuropathy, or less commonly, leukoencephalitis. These chronic neurologic abnormalities usually improve with antibiotic therapy.

Six months after a two-week course of intravenous ceftriaxone (2 g daily), 17 patients (63 percent) had improvement, 6 (22 percent) had improvement but then relapsed, and 4 (15 percent) had no change in their condition.

Six months after treatment, more than one third of the patients either had relapsed or were no better. In addition, more than half had previously received antibiotic therapy thought to be appropriate for their stage of disease and still had progression of the illness. The likely reason for relapse is failure to eradicate the spirochete completely with a two-week course of intravenous ceftriaxone therapy. (Logigian 1990)

MyLymeData

In fact, the MyLymeData study validates that longer antibiotic treatment durationare associated with moderate to a very great deal of improvement. (Johnson 2020)

MyLymeData is currently the largest observational study of patients using real-world data to analyze the response to treatment of chronic Lyme disease patients. The majority of patients (57%) reported treatment durations of four or more months,

The results of this new French study demonstrate the importance of clinicians being able to continue treatment until a patient’s symptoms have resolved. It is clear, at least in this study, that the presence of co-infections greatly compounds one’s disease progress and treatment options.

LymeSci is written by Lonnie Marcum, a Licensed Physical Therapist and mother of a daughter with Lyme. She served two terms on a subcommittee of the federal Tick-Borne Disease Working Group. Follow her on Twitter: @LonnieRhea  Email her at: lmarcum@lymedisease.org.

References

Embers ME, Barthold SW, Borda JT, Bowers L, Doyle L, Hodzic E, et al. Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection. PLoS ONE. 2012;7(1):e29914. Available at: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0029914.

 Johnson, L.; Shapiro, M.; Stricker, R.B.; Vendrow, J.; Haddock, J.; Needell, D. Antibiotic Treatment Response in Chronic Lyme Disease: Why Do Some Patients Improve While Others Do Not? Healthcare 2020, 8, 383. https://www.mdpi.com/2227-9032/8/4/383

Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990 Nov 22;323(21):1438-44. doi: 10.1056/NEJM199011223232102. PMID: 2172819.

Trouillas P, Franck M. Complete Remission in Paralytic Late Tick-Borne Neurological Disease Comprising Mixed Involvement of Borrelia, Babesia, Anaplasma, and Bartonella: Use of Long-Term Treatments with Antibiotics and Antiparasitics in a Series of 10 Cases. Antibiotics. 2023; 12(6):1021. https://doi.org/10.3390/antibiotics12061021

_________________

For more: